Deepline Pharma Private Limited - Company Profile

It is a construction private limited company based in Delhi, Delhi, India, established in 2021.
2021 Delhi, Delhi, India Active
Last Updated:
Access Report
About Deepline Pharma Private Limited

Deepline Pharma Private Limited, a active private limited company, was established on 18 January 2021 in Delhi, Delhi, India. Engaging in other building installation within the construction sector, it holds CIN: U45309DL2021PTC375788. Registered under ROC Roc Delhi I. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Jyoti Rawat (Director), Vijay Kumar Rawat (Director). Past directors included Vipin Bali. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at C-146, Kilokari, Delhi, Delhi, 110014.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U45309DL2021PTC375788

  • Registration Number

    375788

  • Incorporation Date

    18 January 2021

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 5 Year, 1 Month
  • Last Filing with ROC 31 Mar 2025
Company report

Deepline Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Deepline Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Deepline Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Jyoti Rawat Director 09 Mar 2023 Current
Vijay Kumar Rawat Director 18 Jan 2021 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 09 Mar 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Deepline Pharma.

Enhance accessibility to Deepline Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Deepline Pharma revenue growth over time
Deepline Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Deepline Pharma?

Unlock access to Deepline Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Deepline Pharma?

Deepline Pharma has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Deepline Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Deepline Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Deepline Pharma
Recent Activity within the Organization
  • Annual General Meeting

    The activity Deepline Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Deepline Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I. was completed.

  • Director Appointment

    Jyoti Rawat was appointed as a Director was appointed as a Director on 09 Mar 2023 & has been associated with this company since 3 years 1 day . was recorded as a recent event.

  • Director Appointment

    The activity Vijay Kumar Rawat was appointed as a Director was appointed as a Director on 18 Jan 2021 & has been associated with this company since 5 years 1 month . was completed.

  • Company Incorporation

    Deepline Pharma Private Limited was registered on 18 Jan 2021 with Roc Delhi I & aged 5 years 1 month as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Deepline Pharma Private Limited?

The CIN of Deepline Pharma Private Limited is U45309DL2021PTC375788.

Where is Deepline Pharma Private Limited headquartered?

Deepline Pharma Private Limited is headquartered at C-146, Kilokari, Delhi, Delhi, 110014.

When was Deepline Pharma Private Limited incorporated?

Deepline Pharma Private Limited was incorporated on 18 January 2021.

Who are the current directors of Deepline Pharma Private Limited?

The current directors of Deepline Pharma Private Limited are

What is the primary industry of Deepline Pharma Private Limited?

The primary industry of Deepline Pharma Private Limited is Construction.

Is Deepline Pharma Private Limited a listed company?

Deepline Pharma Private Limited is unlisted.

What is the capital structure of Deepline Pharma Private Limited?

The authorized capital of Deepline Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available